175 related articles for article (PubMed ID: 34059433)
21. Human papillomavirus is not an etiologic agent of urothelial inverted papillomas.
Alexander RE; Davidson DD; Lopez-Beltran A; Montironi R; MacLennan GT; Compérat E; Idrees MT; Emerson RE; Cheng L
Am J Surg Pathol; 2013 Aug; 37(8):1223-8. PubMed ID: 23681080
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and correlation of human papilloma virus and its types with prognostic markers in patients with invasive ductal carcinoma of the breast in kuwait.
Francis IM; Al-Ayadhy B; Al-Awadhi S; Kapila K; Al-Mulla F
Sultan Qaboos Univ Med J; 2013 Nov; 13(4):527-33. PubMed ID: 24273662
[TBL] [Abstract][Full Text] [Related]
23. Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast.
Aguiar FN; Mendes HN; Bacchi CE; Carvalho FM
Rev Bras Ginecol Obstet; 2013 Mar; 35(3):97-102. PubMed ID: 23538467
[TBL] [Abstract][Full Text] [Related]
24. Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ?
Tan PH; Aw MY; Yip G; Bay BH; Sii LH; Murugaya S; Tse GM
Am J Surg Pathol; 2005 May; 29(5):625-32. PubMed ID: 15832086
[TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation in ductal carcinoma in situ of the male breast.
Vermeulen MA; van Deurzen CHM; Doebar SC; de Leng WWJ; Martens JWM; van Diest PJ; Moelans CB
Endocr Relat Cancer; 2019 Jun; 26(6):575-584. PubMed ID: 30921768
[TBL] [Abstract][Full Text] [Related]
26. The utility of p16 immunostaining in fine needle aspiration in p16-positive head and neck squamous cell carcinoma.
Xu B; Ghossein R; Lane J; Lin O; Katabi N
Hum Pathol; 2016 Aug; 54():193-200. PubMed ID: 27105759
[TBL] [Abstract][Full Text] [Related]
27. Pathology of breast papillary neoplasms: Community hospital experience.
Vdovenko AA
Ann Diagn Pathol; 2020 Dec; 49():151605. PubMed ID: 32920473
[TBL] [Abstract][Full Text] [Related]
28. Is human papillomavirus associated with breast cancer or papilloma presenting with pathologic nipple discharge?
Balci FL; Uras C; Feldman SM
Cancer Treat Res Commun; 2019; 19():100122. PubMed ID: 30785026
[TBL] [Abstract][Full Text] [Related]
29. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Kerlikowske K; Molinaro AM; Gauthier ML; Berman HK; Waldman F; Bennington J; Sanchez H; Jimenez C; Stewart K; Chew K; Ljung BM; Tlsty TD
J Natl Cancer Inst; 2010 May; 102(9):627-37. PubMed ID: 20427430
[TBL] [Abstract][Full Text] [Related]
30. Discrimination of 'driver' and 'passenger' HPV in tonsillar carcinomas by the polymerase chain reaction, chromogenic in situ hybridization, and p16(INK4a) immunohistochemistry.
Evans MF; Matthews A; Kandil D; Adamson CS; Trotman WE; Cooper K
Head Neck Pathol; 2011 Dec; 5(4):344-8. PubMed ID: 21786153
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA chromogenic in situ hybridisation signal pattern correlation with breast tumour pathology.
Zhang Z; Weaver DL; Olsen D; deKay J; Peng Z; Ashikaga T; Evans MF
J Clin Pathol; 2016 Jan; 69(1):76-81. PubMed ID: 26323944
[TBL] [Abstract][Full Text] [Related]
32. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
[TBL] [Abstract][Full Text] [Related]
33. A useful immunohistochemical approach to evaluate intraductal proliferative lesions of the breast and to predict their prognosis.
Omi Y; Yamamoto T; Okamoto T; Obara T; Kobayashi M
Histol Histopathol; 2011 Jan; 26(1):79-86. PubMed ID: 21117029
[TBL] [Abstract][Full Text] [Related]
34. Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically.
Subhawong AP; Subhawong T; Nassar H; Kouprina N; Begum S; Vang R; Westra WH; Argani P
Am J Surg Pathol; 2009 Feb; 33(2):163-75. PubMed ID: 18936692
[TBL] [Abstract][Full Text] [Related]
35. Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesions.
Mao X; Qiao Z; Fan C; Guo A; Yu X; Jin F
Oncol Rep; 2016 Oct; 36(4):1868-74. PubMed ID: 27498697
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of HPV status and p16 expression in patients with carcinoma of the anal canal.
Roldán Urgoiti GB; Gustafson K; Klimowicz AC; Petrillo SK; Magliocco AM; Doll CM
PLoS One; 2014; 9(10):e108790. PubMed ID: 25271758
[TBL] [Abstract][Full Text] [Related]
37. The long-term psychosocial consequences of screen-detected ductal carcinoma in situ and invasive breast cancer.
Gram EG; Manso TFR; Heleno B; Siersma V; Á Rogvi J; Brodersen JB
Breast; 2023 Aug; 70():41-48. PubMed ID: 37307773
[TBL] [Abstract][Full Text] [Related]
38. High-risk human papillomavirus infection and p16INK4a protein expression in laryngeal lesions.
Laco J; Slaninka I; Jirásek M; Celakovský P; Vosmiková H; Ryska A
Pathol Res Pract; 2008; 204(8):545-52. PubMed ID: 18440161
[TBL] [Abstract][Full Text] [Related]
39. Identification of human papillomavirus in esophageal squamous papillomas.
Bohn OL; Navarro L; Saldivar J; Sanchez-Sosa S
World J Gastroenterol; 2008 Dec; 14(46):7107-11. PubMed ID: 19084918
[TBL] [Abstract][Full Text] [Related]
40. Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer.
Mustafa RE; DeStefano LM; Bahng J; Yoon-Flannery K; Fisher CS; Zhang PJ; Tchou J; Czerniecki BJ; De La Cruz LM
Ann Surg Oncol; 2017 Oct; 24(10):2999-3003. PubMed ID: 28766212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
